CWRU's members of the 2022 NAI class are Dr. Sanford Markowitz and Dustin Tyler, Ph.D. The honor highlights individuals whose spirit of innovation and technical expertise have made an impact in their field and on society.
2 health sciences professors named fellows of the National Academy of Inventors scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.
Pioneer in RNA nanotechnology named Ohio State Innovator of the Year
Leaders offer vision for the future at Research and Innovation Showcase 614.292.7276
Peixuan Guo, the Sylvan Frank Endowed Chair in Pharmaceutics and Drug Delivery and the director of the College of Pharmacy Center for RNA Nanotechnology and Nanomedicine, is The Ohio State University 2021 Innovator of the Year.
Guo is a pioneer of RNA nanotechnology, developing RNA particles that target tumors. His work has led to several discoveries: the RNA rubbery property that leads to more efficient cancer targeting without toxicity, novel methods for lung and liver cancer therapies, and a simple and fast method for diagnosing COVID-19 earlier in infection.
Share
Peixuan Guo, the Sylvan Frank Endowed Chair in Pharmaceutics and Drug Delivery and the director of the College of Pharmacy Center for RNA Nanotechnology and Nanomedicine, is The Ohio State University 2021 Innovator of the Year.
Guo is a pioneer of RNA nanotechnology, developing RNA particles that target tumors. His work has led to several discoveries: the RNA rubbery property that leads to more efficient cancer targeting without toxicity, novel methods for lung and liver cancer therapies, and a simple and fast method for diagnosing COVID-19 earlier in infection.
He first proposed the concept that cells have many small RNA molecules with novel yet undiscovered functions, and named them “sRNA.” Guo is the founder and chairman of the board of directors of ExonanoRNA LLC. He has raised more than $4 million of funding for the company to develop RNA nanoparticles for cancer therapy.
E-Mail
IMAGE: Drug delivery reseracher Kevi Li is a professor and pharmaceutical scientist at the University of Cincinnati s James L. Winkle College of Pharmacy. view more
Credit: University of Cincinnati
Getting poked in the eye with a sharp object is a cringeworthy thought. However, many patients with posterior eye diseases back of the eye diseases such as macular degeneration or diabetic retinopathy undergo eye injections through the wall of the eye as a medical treatment on a regular basis. Direct injections of medications into the eye are not only an unpleasant experience but repeated injections can lead to severe adverse effects to the eye, which can be sight-threatening, says Kevin Li, a University of Cincinnati pharmaceutical scientist who is leading a new research study of an alternative treatment for posterior eye diseases.